F. Esteva

发表论文 354 篇 · 总被引 24657 次 · h-index 79

代表论文

Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial. (2020 · The Lancet Oncology · 被引 306)
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer (2021 · British Journal of Cancer · 被引 86)
Next-Generation HER2-Targeted Antibody–Drug Conjugates in Breast Cancer (2024 · Cancers · 被引 53)
Overall survival (OS) in KATE2, a phase II study of programmed death ligand 1 (PD-L1) inhibitor atezolizumab (atezo)+trastuzumab emtansine (T-DM1) vs placebo (pbo)+T-DM1 in previously treated HER2+ advanced breast cancer (BC) (2019 · Annals of Oncology · 被引 52)
Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study (2020 · Breast · 被引 40)
Efficacy and safety of the combination of metformin, everolimus and exemestane in overweight and obese postmenopausal patients with metastatic, hormone receptor-positive, HER2-negative breast cancer: a phase II study (2019 · Investigational new drugs · 被引 31)